OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Cash & Current Investments (2023 - 2026)

OSR Health (OSRHW) posted Cash & Current Investments of $1.8 million for Q1 2026, down 6.97% sequentially from $2.0 million in Q4 2025, and up 10.66% YoY from $1.7 million in Q1 2025.

OSR Health (OSRHW) Cash & Current Investments (2023 - 2026) Analysis & Trends

OSR Health has reported Cash & Current Investments for 4 years, with the latest figure at $1.8 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 10.66% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 10.66% YoY) and the FY2025 annual result came in at $2.0 million, up 395.75% from the prior year.
  • Cash & Current Investments eased to $1.8 million in Q1 2026 per OSRHW's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $70.6 million in Q1 2023 and troughed at $3637.0 in Q1 2024.
  • A 4-year average of $7.3 million and a median of $1.6 million in 2025 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 99.99% in 2024, then surged 45273.91% in 2025.
  • Over 4 years, Cash & Current Investments stood at $15419.0 in 2023, then jumped by 2468.03% to $395965.0 in 2024, then surged by 395.75% to $2.0 million in 2025, then retreated by 6.97% to $1.8 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $1.8 million, $2.0 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn 5.18 Bn
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn 18.39 Bn
8 Royalty Pharma 27.29 Bn 26.45 Bn - 836.99 Mn
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn 1.16 Bn
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 1.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Dec 31, 2025 1.96 Mn
Sep 30, 2025 2.23 Mn
Jun 30, 2025 1.64 Mn
Mar 31, 2025 1.65 Mn
Dec 31, 2024 395,965.00
Sep 30, 2024 12,236.00
Mar 31, 2024 3,637.00
Dec 31, 2023 15,419.00
Sep 30, 2023 57,955.00
Mar 31, 2023 70.63 Mn